These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 24722246)

  • 1. I prostanoid receptor-mediated inflammatory pathway promotes hepatic gluconeogenesis through activation of PKA and inhibition of AKT.
    Yan S; Zhang Q; Zhong X; Tang J; Wang Y; Yu J; Zhou Y; Zhang J; Guo F; Liu Y; FitzGerald GA; Yu Y
    Diabetes; 2014 Sep; 63(9):2911-23. PubMed ID: 24722246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
    Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
    Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GdCl3 reduces hyperglycaemia through Akt/FoxO1-induced suppression of hepatic gluconeogenesis in Type 2 diabetic mice.
    Wang Q; Wang N; Dong M; Chen F; Li Z; Chen Y
    Clin Sci (Lond); 2014 Jul; 127(2):91-100. PubMed ID: 24444370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dapper1 attenuates hepatic gluconeogenesis and lipogenesis by activating PI3K/Akt signaling.
    Kuang JR; Zhang ZH; Leng WL; Lei XT; Liang ZW
    Mol Cell Endocrinol; 2017 May; 447():106-115. PubMed ID: 28237722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin F
    Wang Y; Yan S; Xiao B; Zuo S; Zhang Q; Chen G; Yu Y; Chen D; Liu Q; Liu Y; Shen Y; Yu Y
    Diabetes; 2018 Sep; 67(9):1748-1760. PubMed ID: 29773555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiopoietin-like protein 8 (betatrophin) inhibits hepatic gluconeogenesis through PI3K/Akt signaling pathway in diabetic mice.
    Zhao Z; Deng X; Jia J; Zhao L; Wang C; Cai Z; Guo C; Yang L; Wang D; Ma S; Deng J; Li H; Zhou L; Tu Z; Yuan G
    Metabolism; 2022 Jan; 126():154921. PubMed ID: 34715116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DMT efficiently inhibits hepatic gluconeogenesis by regulating the Gαq signaling pathway.
    Zhou TT; Ma F; Shi XF; Xu X; Du T; Guo XD; Wang GH; Yu L; Rukachaisirikul V; Hu LH; Chen J; Shen X
    J Mol Endocrinol; 2017 Aug; 59(2):151-169. PubMed ID: 28637808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1.
    Herzig S; Long F; Jhala US; Hedrick S; Quinn R; Bauer A; Rudolph D; Schutz G; Yoon C; Puigserver P; Spiegelman B; Montminy M
    Nature; 2001 Sep; 413(6852):179-83. PubMed ID: 11557984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular visfatin activates gluconeogenesis in HepG2 cells through the classical PKA/CREB-dependent pathway.
    Choi YJ; Choi SE; Ha ES; Kang Y; Han SJ; Kim DJ; Lee KW; Kim HJ
    Horm Metab Res; 2014 Apr; 46(4):233-9. PubMed ID: 24627100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FAM3A activates PI3K p110α/Akt signaling to ameliorate hepatic gluconeogenesis and lipogenesis.
    Wang C; Chi Y; Li J; Miao Y; Li S; Su W; Jia S; Chen Z; Du S; Zhang X; Zhou Y; Wu W; Zhu M; Wang Z; Yang H; Xu G; Wang S; Yang J; Guan Y
    Hepatology; 2014 May; 59(5):1779-90. PubMed ID: 24806753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nuclear bile acid receptor FXR is a PKA- and FOXA2-sensitive activator of fasting hepatic gluconeogenesis.
    Ploton M; Mazuy C; Gheeraert C; Dubois V; Berthier A; Dubois-Chevalier J; Maréchal X; Bantubungi K; Diemer H; Cianférani S; Strub JM; Helleboid-Chapman A; Eeckhoute J; Staels B; Lefebvre P
    J Hepatol; 2018 Nov; 69(5):1099-1109. PubMed ID: 29981427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Jieduquyuziyin Prescription alleviates hepatic gluconeogenesis via PI3K/Akt/PGC-1α pathway in glucocorticoid-induced MRL/lpr mice.
    Ji LN; Wu S; Fu DQ; Fang SJ; Xie GQ; Fan YS; Bao J
    J Ethnopharmacol; 2022 Feb; 284():114815. PubMed ID: 34763039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term co-administration of sodium nitrite and sodium hydrosulfide inhibits hepatic gluconeogenesis in male type 2 diabetic rats: Role of PI3K-Akt-eNOS pathway.
    Jeddi S; Gheibi S; Carlström M; Kashfi K; Ghasemi A
    Life Sci; 2021 Jan; 265():118770. PubMed ID: 33212150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine-phosphorylated DNER sensitizes insulin signaling in hepatic gluconeogenesis by inducing proteasomal degradation of TRB3.
    Li J; Huang Y; Yang X; Cai Y; Wang Y; Dai W; Jiang L; Wang C; Wen Z
    Mol Metab; 2024 May; 83():101927. PubMed ID: 38553003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic p38α regulates gluconeogenesis by suppressing AMPK.
    Jing Y; Liu W; Cao H; Zhang D; Yao X; Zhang S; Xia H; Li D; Wang YC; Yan J; Hui L; Ying H
    J Hepatol; 2015 Jun; 62(6):1319-27. PubMed ID: 25595884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APPL1 potentiates insulin-mediated inhibition of hepatic glucose production and alleviates diabetes via Akt activation in mice.
    Cheng KK; Iglesias MA; Lam KS; Wang Y; Sweeney G; Zhu W; Vanhoutte PM; Kraegen EW; Xu A
    Cell Metab; 2009 May; 9(5):417-27. PubMed ID: 19416712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin Suppresses Hepatic Glucagon Signaling Through Decreasing Production of Thromboxane A2.
    Dai Y; Xu R; Wu G; Yin Z; Zhang H; Li H; Chen W
    Endocrinology; 2023 Jan; 164(3):. PubMed ID: 36592127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small Hepatitis B Virus Surface Antigen Promotes Hepatic Gluconeogenesis via Enhancing Glucagon/cAMP/Protein Kinase A/CREB Signaling.
    Chen Y; Wang B; Ou X; Wu Y; He Y; Lin X; Lin X
    J Virol; 2022 Dec; 96(23):e0102022. PubMed ID: 36394315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GLP-1-derived nonapeptide GLP-1(28-36)amide represses hepatic gluconeogenic gene expression and improves pyruvate tolerance in high-fat diet-fed mice.
    Ip W; Shao W; Chiang YT; Jin T
    Am J Physiol Endocrinol Metab; 2013 Dec; 305(11):E1348-58. PubMed ID: 24085036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin acts through MT1/MT2 receptors to activate hypothalamic Akt and suppress hepatic gluconeogenesis in rats.
    Faria JA; Kinote A; Ignacio-Souza LM; de Araújo TM; Razolli DS; Doneda DL; Paschoal LB; Lellis-Santos C; Bertolini GL; Velloso LA; Bordin S; Anhê GF
    Am J Physiol Endocrinol Metab; 2013 Jul; 305(2):E230-42. PubMed ID: 23695212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.